Cannabis Investors: Ignore This Stock at Your Own Risk

Here is why Charlotte’s Web Holdings (TSX:CWEB) is one of the best stocks to buy in the cannabis market.

| More on:

It may be tempting for investors looking to jump on the marijuana bandwagon to focus on the Canadian pot market. After all, Canada is still the only country in the developed world in which recreational uses of marijuana are legal. Sales of cannabis are projected to grow at an exponential rate in the country, and there are definitely many marijuana companies worth considering.

However, the U.S. market is the largest market in the world, and despite marijuana not yet being legal at the federal level, the CBD market is booming. Let’s see why Charlotte’s Web Holdings (TSX:CWEB), a Colorado-based company, is one of the best ways to cash in on the U.S. market.

One of the biggest players in the US CBD market

By way of a reminder, the Farm Bill that was enacted late last year in the U.S.-made hemp — and hemp-derived CBD — legal at the federal level. Hemp contains negligible amounts of tetrahydrocannabinol (THC), the chemical component in weed that induces the euphoric or “high” feeling in its users.

CBD and CBD-derived products are often lauded for their various medical benefits. These include the positive effects of CBD oil on those suffering of depression and anxiety.

Charlotte’s Web holds a strong market share within the U.S. CBD market. The firm offers various CBD-derived products, including oils, capsules, and topicals, hemp products for dogs, and the company delivers strong sales for every product category. Indeed, Charlotte’s Web holds the largest market share among competitors in this market in the U.S.

Last year, the company produced 675,000 pounds of hemp (about 306,174 kilograms), which is very competitive by industry’s standard. But Charlotte’s Web is projected to produce even more this year. The firm recently announced plans to increase its total hemp acres planted for 2019 to 862, which represents a 187% increase from last year.

In a press release, Deanie Elsner, CEO of Charlotte’s Web said the following: “Interest and demand for our products has been exceptional and growing rapidly. Our 2019 planting strategy ensures we will have the required raw materials to deliver on production targets for Charlotte’s Web products through 2020 and into 2021.”

This rise in demand of CBD products should continue for the foreseeable future. With over 6000 retail locations in the U.S., the firm’s products are sold or shipped in all 50 states of the union.

Financial results

Charlotte’s Web reported its Q1 financial results last month. The company’s USD $21.7 million revenue represented a 66% year over year growth, and its gross profit rose by 53%. While the firm’s earnings before taxes decreased by 27% and its net income decreased by 26%, Charlotte’s Web is managing to do something few of its peers are doing: recording consistent profits.

The company expects revenues to grow at a faster pace than expenses for the rest of the year. With a rise in demand for its products, Charlotte’s Web seems well positioned to keep its earnings rising. 

Should you buy?

The U.S. CBD market will be an even bigger opportunity than the Canadian marijuana market, and Charlotte’s Web is currently the biggest player in this market. The Colorado-based company — which also happens to already be consistently profitable — might just be one of the best ways to benefit from this golden opportunity.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Prosper Bakiny has no position in any of the stocks mentioned.  

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »